<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>51-ACETYLCHOLINESTERASE-INHIBITORS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="ACETYL-CHOLINESTERASE INHIBITORS" code="ACETCHO" /></DRUG1>
<DRUG2>
<CLASS name="BETA-BLOCKING AGENTS IN HEART FAILURE" code="C07AB-003" /></DRUG2>
<DESCRIPTION>Risk of excessive bradycardia (addition of the bradycardia inducing effects)

</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Regular clinical monitoring, especially at the beginning of the administration of the substances together </COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>51-ACETYLCHOLINESTERASE-INHIBITORS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="ACETYL-CHOLINESTERASE INHIBITORS" code="ACETCHO" /></DRUG1>
<DRUG2>
<DRUG name="PILOCARPINE" rxcui="8328">
<ATC code="N07AX01" />
<ATC code="S01EB01" />
<ATC code="S01EB51" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of addition of the undesirable cholinergic effects, especially digestive ones</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>51-ACETYLCHOLINESTERASE-INHIBITORS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="ACETYL-CHOLINESTERASE INHIBITORS" code="ACETCHO" /></DRUG1>
<DRUG2>
<DRUG name="SUXAMETHONIUM" rxcui="10154">
<ATC code="M03AB01" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of lengthening of the motor block, increased in the case of partial deficit of pseudocholinesterase</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
</INTERACTIONS>
